Dr. Thomas Wolter
European Patent Attorney, Partner, Mewburn Ellis, Munich (Germany)
Thomas qualified as German and European Patent Attorney in 1999 and has practiced at a German patent law firm before joining Mewburn Ellis in 2020. He is particularly interested in plausibility. Thomas represented the patentee in the dasatinib cases at the EPO, gave presentations about plausibility, and ran a workshop on plausibility at the FICPI World Congress 2022. He has a double Master’s degree in chemistry and biology from Ruhr-Universität Bochum, Germany, and a PhD from Université Louis Pasteur Strasbourg, France.
Julie Chiu
Attorney-at-Law, Senior Associate (Australian Qualified), Taylor Wessing, London (UK)
Julie is an IP lawyer with a particular focus on in life sciences. Julie's experience includes advising global pharmaceutical companies on patent validity and infringement issues and pan-European litigation coordination. Julie has a technical background in genetics and molecular biology, and is admitted to practice in Australia.
Victoria Coleman
Senior Associate, European Patent Attorney, Mewburn Ellis, London (UK)
Victoria is involved in the drafting and prosecution of chemistry patents, as well as oppositions and appeals at the European Patent Office. She also undertakes Freedom to Operate work and validity opinions. Victoria joined Mewburn Ellis in 2018, qualifying as a European Patent Attorney in 2018 and a Chartered Patent Attorney in 2019. Her areas of expertise are small molecule drug candidates, antibody-drug conjugates, pharmaceutical formulations, chemical processes and compositions. She has a Master’s degree in chemistry and patent law from Manchester University.
27/03/2025
27/03/2025
From 09:00 - 17:00 CET
online
online
Veranstaltung - 1,280 € zzgl. MwSt.
The fee includes the 'live' participation via internet, high-quality course material for download, a participation certificate as well as technical support including a test meeting.
Veranstaltung - 1,280 € zzgl. MwSt.
The fee includes the 'live' participation via internet, high-quality course material for download, a participation certificate as well as technical support including a test meeting.
Jean-Claude Alexandre Ho, LL.M.
Lawyer, Conference Manager
+49 6221 500-675
jc.alexandreho@forum-institut.de
This online course deals with the impact of G2/21 on plausibility and shall enable participants to reduce exposure to G2/21 challenges.
A doctrine of "plausibility" has been adopted by some patent offices, including the EPO, under which post-filed data that supports
the existence of a "technical effect" is only evaluated where the application as originally filed renders the effect plausible.
This online course will turn on the issue of when a technical effect demonstrated by post filed data can be taken into account.
An issue underlying the doctrine of "plausibility" is the extent to which the technical effect should be supported by the
application as filed for any post filed evidence to be considered. There is a relationship between the role of a "technical
effect" in protecting inventions and the level of disclosure of the technical effect that must be given in the application as filed.
The course will explore how this relationship has shaped outcomes in various cases and led to the referral to the EPO's Enlarged
Board of Appeal before we turn to the EBA's guidance in G2/21. It seems to be common ground that G2/21 has not (yet) made the
EPO practitioner's life easier. The abstractness of the criteria set forth by the EBA requires due consideration. We will also be exploring how the Board of Appeal and Opposition divisions have applied G2/21 thus far. We will re-engineer a number of past cases and their outcomes against the guidance given in G2/21.
of 5 stars of all ratings from 2023
of 5 stars on Trustpilot = good
This live webcast provides you regularly with the discussion of the latest UPC cases and their impact on legal practice.
This live webcast provides you regularly with the discussion of the latest UPC cases and their impact on legal practice.
This live webcast provides you regularly with the discussion of the latest UPC cases and their impact on legal practice.
In diesem Seminar wird die aktuelle Rechtsprechung des X. Zivilsenats des BGH im Querschnitt und in ihrer Vernetzung in ...
Our speaker, one of the leading SPC experts in Europe, will discuss the SPC referrals to the ECJ with you. He will put t...
Download this whitepaper with the views of ~400 IP professionals.
DetailsDownload this whitepaper for an overview of IP audits in companies
DetailsDownload this whitepaper and get insights on the patent creation process.
Details